×

Cereplast Reports Financial Results for the First Six Months of 2013

Cereplast, Inc. Logo

SEYMOUR, Ind., Aug. 14, 2013 (GLOBE NEWSWIRE) -- Cereplast, Inc. (OTCQB:CERP) (the "Company"), a leading manufacturer of proprietary biobased, compostable and sustainable bioplastics, today announced $1.7 million in net revenues during the first half of 2013 compared to $305,000 for the same period the prior year and $911,000 for all of 2012.

Cereplast Chairman and Chief Executive Officer, Mr. Frederic Scheer, stated, "On a comparable basis to 2012, we are pleased with the revenue growth we have enjoyed thus far in 2013. The majority of this growth is from Italy, and we expect this trend to accelerate as legislation is officially passed. In addition to our focus in Italy, we have taken aggressive steps to strengthen our sales team in India and North America and have already received orders. Both geographic areas have the potential to provide significant sales opportunities for the Company. We anticipate comparable growth to occur during the remainder of the year and have received several orders that are expected to begin shipping during the fourth quarter."

2013 Operational Highlights to Date:

  • As of June 1, 2013, the Company successfully completed its corporate restructuring by relocating its corporate headquarters from California to its production facility in Indiana, as well as by relocating its European headquarters from Germany to its offices in Italy. The closure of the offices in California and Germany is expected to reduce annual operating expenses by $600,000 to $800,000.
  • The Company received multiple purchase orders for its Cereplast Compostables® blown film resins totaling approximately $200,000. These resins will be used for the manufacture of single-use plastic bags for use at about 45 supermarkets located in the Veneto and Trentino Regions in Italy. The resin is being produced this month at the Company's manufacturing facility in Indiana.
  • Cereplast strengthened its North American sales team through the appointment Mr. Reddy Tudi as Vice President of Business Development and Mr. Kevin J. Fina as Regional Sales Manager. Together, Mr. Tudi and Mr. Fina are working on approximately 30 projects in North America for Cereplast Compostables® blown film and blow molding resins, as well as Cereplast Sustainables® resins for injection molding applications. The potential volume of these projects is $10 million per year.
  • The Company recently received and shipped orders to both new and existing customers in India, one of which is a well-known polymer solution provider that has been in business for over ten years in Hyderbad, India.

2013 First Six Months Financial Results:

Net sales for the six months ended June 30, 2013 were approximately $1.7 million, compared to $0.3 million in the same period in 2012. Sales increased from the prior year due to growing demand in the European markets primarily due to pending legislation in Italy that will ban traditional plastic bags.

Cost of sales is comprised of variable costs associated with product revenues. Cost of sales for the six months ended June 30, 2013 was approximately $1.5 million, compared to $0.4 million for the same period in 2012. The increase in cost of sales is due to an increase in sales.

Gross profit (loss) for the six months ended June 30, 2013 was approximately $0.2 million, compared to ($0.1) million for the same period in 2012. The increase in gross profit was attributable to an increase in sales as stated above.

Research and development expenses for the six months ended June 30, 2013 were $0.2 million, compared to approximately $0.3 million for the same period in 2012. Research and development expenses have slightly decreased due to cost containment efforts to preserve working capital.

Selling, general and administrative expenses for the six months ended June 30, 2013 were $2.7 million, compared to $3.7 million for the same period in 2012. The decrease in sales, general and administrative expenses was primarily due to reduced headcount and a reduction in fixed production overhead costs classified as selling, general and administrative expense due to an extended period of abnormally low production volume.

Other income and expense, net for the six months ended June 30, 2013 was primarily non-cash net expenses of $24.1 million, as compared to a net expense of $2.3 million in the same period in 2012. The increase in other income and expense was primarily a result of the change in the derivative liability related to warrants, short-term convertible debt and preferred stock agreements. In addition, the Company recorded $1.8 million in debt extinguishment costs related to the exchange of certain term loan and convertible notes.

Net loss for the six months ended June 30, 2013 was $26.8 million, as compared to $6.3 million in the same period in 2012.

2013 Second Quarter Financial Results:

Net sales for the three months ended June 30, 2013 were approximately $0.7 million, compared to $0.2 million in the same period in 2012.

Cost of sales is comprised of variable costs associated with product revenues. Cost of sales for the three months ended June 30, 2013 was approximately $0.7 million, compared to $0.2 million for the same period in 2012.

Gross profit (loss) for the three months ended June 30, 2013 was approximately $0.1 million, compared to $7,000 for the same period in 2012.

Research and development expenses for the three months ended June 30, 2013 were $0.1 million, compared to approximately $0.1 million for the same period in 2012. Research and development expenses have not increased due to the Company's cost containment effort to preserve working capital.

Selling, general and administrative expenses for the three months ended June 30, 2013 were $1.2 million, compared to $2.0 million for the same period in 2012. The decrease in sales, general and administrative expenses was primarily due to reduced headcount and a reduction in fixed production overhead costs classified as selling, general and administrative expense due to an extended period of abnormally low production volume.

Other income and expense, net for the three months ended June 30, 2013 was primarily non-cash net expenses of $7.5 million, as compared to a net expense of $1.8 million in the same period in 2012. The increase in expense was primarily a result of the change in derivative liability related to the Company's warrants, short-term convertible debt and preferred stock agreements.

Net loss for the three months ended June 30, 2013 was $8.7 million, as compared to $3.9 million in the same period in 2012.

Conference Call Details:
Date: Wednesday, August 14th
Time: 4:30 p.m. Eastern
Participant Dial-In: (480) 629-9666
Live Webcast: http://www.cereplast.com/investors/events-presentations/

It is recommended that participants dial in approximately 10 minutes prior to the start of the 4:30 p.m. Eastern call. There will also be a simultaneous live webcast of the conference call which can be accessed through the following audio feed link and archived recording of the conference call available under the Investor Relations section of the company website at http://www.cereplast.com/investors/events-presentations/.

About Cereplast, Inc.

Cereplast, Inc. (OTCQB:CERP) designs and manufactures proprietary biobased, sustainable bioplastics which are used as substitutes for traditional plastics in all major converting processes - such as injection molding, thermoforming, blow molding and extrusions - at a pricing structure that is competitive with traditional plastics. On the cutting-edge of biobased plastic material development, Cereplast now offers resins to meet a variety of customer demands. Cereplast Compostables® resins are ideally suited for single-use applications where high biobased content and compostability are advantageous, especially in the food service industry. Cereplast Sustainables® resins combine high biobased content with the durability and endurance of traditional plastic, making them ideal for applications in industries such as automotive, consumer electronics and packaging. Learn more at www.cereplast.com. You may also visit the Cereplast social networking pages at Facebook.com/Cereplast, Twitter.com/Cereplast and Youtube.com/Cereplastinc.

Safe Harbor Statement

Matters discussed in this press release contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. When used in this press release, the words "anticipate," "believe," "estimate," "may," "intend," "expect" and similar expressions identify such forward-looking statements. Actual results, performance or achievements could differ materially from those contemplated, expressed or implied by the forward-looking statements contained herein. These forward-looking statements are based largely on the expectations of the Company and are subject to a number of risks and uncertainties. These include, but are not limited to, risks and uncertainties associated with: the impact of economic, competitive and other factors affecting the Company and its operations, markets, product, and distributor performance, the impact on the national and local economies resulting from terrorist actions, and U.S. actions subsequently; and other factors detailed in reports filed by the Company.

CEREPLAST, INC.
CONSOLIDATED BALANCE SHEETS
(in thousands, except shares data)
June 30, 2013 December 31, 2012
(Unaudited)
ASSETS
Current Assets
Cash $ 223 $ 183
Accounts Receivable, Net 1,166 149
Inventory, Net 5,444 6,941
Prepaid Expenses and Other Current Assets 178 227
Total Current Assets 7,011 7,500
Property and Equipment
Property and Equipment 11,535 11,601
Accumulated Depreciation and Amortization (4,433) (4,004)
Property and Equipment, Net 7,102 7,597
Other Assets
Restricted Cash -- 43
Deferred Loan Costs 484 750
Intangible Assets, Net 241 245
Deposits 48 47
Total Other Assets 773 1,085
Total Assets $ 14,886 $ 16,182
LIABILITIES AND SHAREHOLDERS' DEFICIT
Current Liabilities
Accounts Payable $ 968 $ 803
Accrued Expenses 3,406 3,663
Capital Leases, Current Portion 97 85
Loan Payable, Current Portion 5,762 5,978
Convertible Subordinated Notes, Current Portion 819 891
Derivative Liability 13,739 3,189
Preferred Stock, $0.001 par value; 5,000,000 shares authorized; 294 and 92 shares issued and outstanding at June 30, 2013 and December 31, 2012, respectively 1,213 500
Total Current Liabilities 26,004 15,109
Long-Term Liabilities
Loan Payable 452 923
Convertible Subordinated Notes 8,176 10,000
Capital Leases, Long-Term 131 173
Total Long-Term Liabilities 8,759 11,096
Total Liabilities 34,763 26,205
Shareholders' Deficit
Common Stock, $0.001 par value; 2,000,000,000 shares authorized; 622,359,545 and 63,463,659 shares issued and outstanding at June 30, 2013 and December 31, 2012, respectively 622 63
Common Stock Subscribed, not issued 586 --
Additional Paid in Capital 92,738 76,919
Accumulated Deficit (113,865) (87,097)
Accumulated Other Comprehensive Income 38 88
(19,881) (10,027)
Noncontrolling Interests 4 4
Total Shareholders' Deficit (19,877) (10,023)
Total Liabilities and Shareholders' Deficit $ 14,886 $ 16,182
CEREPLAST, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS AND OTHER COMPREHENSIVE INCOME
(unaudited, in thousands, except per share data)
Three Months Ended Six Months Ended
June 30, 2013 June 30, 2012 June 30, 2013 June 30, 2012
Gross Product Sales $ 747 $ 191 $ 1,697 $ 305
Sales Discounts, Returns and Allowances -- (1) (1) (12)
Net Sales 747 190 1,696 293
Cost of Goods Sold 654 197 1,498 387
Gross Profit (Loss) 93 (7) 198 (94)
Operating Expenses:
Research and Development 114 126 220 255
Selling, General and Administrative 1,159 2,009 2,662 3,673
Total Operating Expenses 1,273 2,135 2,882 3,928
Operating Loss (1,180) (2,142) (2,684) (4,022)
Debt Extinguishment Costs (173) (427) (1,756) (427)
Change in Derivative Liability (5,921) (99) (19,237) (99)
Interest and Other Income -- -- -- 18
Interest Expense (1,442) (1,253) (3,091) (1,777)
Loss Before Provision for Income Taxes (8,716) (3,921) (26,768) (6,307)
Provision for Income Taxes -- -- -- --
Net Loss $ (8,716) $ (3,921) $ (26,768) $ (6,307)
Net Loss Per Share - Basic and Diluted $ (0.02) $ (0.20) $ (0.08) $ (0.32)
Weighted Average Common Shares Outstanding - Basic and Diluted 474,847,995 19,947,205 355,084,811 19,471,441
CEREPLAST, INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(unaudited, in thousands, except shares data)
Six Months Ended
June 30, 2013 June 30, 2012
CASH FLOWS FROM OPERATING ACTIVITIES:
Net Loss $ (26,768) $ (6,307)
Adjustment to Reconcile Net Loss to Net Cash Used in Operating Activities
Depreciation and Amortization 435 356
Common Stock Issued for Services, Salaries and Wages 87 143
Amortization of Loan Discount 2,254 779
Extinguishment of Convertible Debt 1,756 348
Change in Warrant Derivative Liability 19,237 99
Allowance for Doubtful Accounts -- 521
Changes in Operating Assets and Liabilities
Accounts Receivable (1,020) (95)
Deferred Loan Costs 265 262
Inventory 1,460 336
Prepaid Expenses 49 2
Restricted Cash 43 --
Accounts Payable 164 (402)
Accrued Expenses 621 34
NET CASH USED IN OPERATING ACTIVITIES (1,417) (3,924)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of Property and Equipment, and Intangibles (3) (125)
Proceeds from Sale of Equipment -- 15
NET CASH USED IN INVESTING ACTIVITIES (3) (110)
CASH FLOWS FROM FINANCING ACTIVITIES:
Payments on Capital Leases (30) (36)
Payments made on Notes Payable -- (603)
Proceeds from Convertible Notes, Net of Issuance Costs 63 450
Proceeds from Issuance of Preferred Stock 1,500 --
Proceeds from Issuance of Common Stock and Subscriptions, Net of Issuance Costs (23) 488
NET CASH PROVIDED BY FINANCING ACTIVITIES 1,510 299
FOREIGN CURRENCY TRANSLATION (50) (15)
NET INCREASE (DECREASE) IN CASH 40 (3,750)
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD 183 3,940
CASH AND CASH EQUIVALENTS, END OF PERIOD $ 223 $ 190

CONTACT: Cereplast, Inc. Public Relations Nicole Robertson 812.220.5400 X1013 nrobertson@cereplast.com Investor Relations: Alliance Advisors, LLC Valter Pinto 914-669-0222 x201 valter@allianceadvisors.net www.AllianceAdvisors.net

Source:Cereplast, Inc.